Skip to main content
MedPathMedPath Home
Clinical Trials/PER-064-02
PER-064-02
Completed
未知

EVALUATION OF THE EFFICACY AND SAFETY OF THE CO-ADMINISTRATION OF PHENOFIBRATE AND EZETIMIBE IN PATIENTS WITH MIXED HYPERLIPIDEMIA - GENOMIC AMENDMENT

MERCK SHARP & DOHME PERU S.R.L.,0 sites0 target enrollmentOctober 28, 2002
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
MERCK SHARP & DOHME PERU S.R.L.,
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 28, 2002
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
MERCK SHARP & DOHME PERU S.R.L.,

Eligibility Criteria

Inclusion Criteria

  • •If they are adults between 18 and 75 years of age.
  • •Men, women in post\-menopausal stage or women in premenopausal age:
  • •both sterilized surgically and with high probabilities of not conceiving, and with a negative pregnancy test in Visit 1\.

Exclusion Criteria

  • •a. Chronic cardiac dysfunction NYHA Classes m or IV.
  • •b. Cardiac arrhythmias not controllable.
  • •c. History of CHD disease or equivalent to CHD (except diabetes mellitus), or a risk of developing CHD\> 20%, as established by the NCEP ATP Ht criteria (see Appendix 7 for definitions).
  • •d. History of pancreatitis.
  • •e. Unstable hypertension (systolic pressure\> 160 mm Hg or diastolic pressure\> 100 mm Hg) at Visit 1\.
  • •f. Disorders of the haematological, digestive, or central nervous system including the degenerative disease that would limit the evaluation or participation in the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 4
Evaluation of the TEKTONA® system designed to restore vertebral height in the treatment of vertebral fractures by compressioVertebral compression fracture, stable type, without neurological deficitMusculoskeletal Diseases
ISRCTN10328801Spineart (Switzerland)37
Active, not recruiting
Phase 1
An evaluation of the safety and effectiveness of combination therapy using the thiazolidinedione pioglitazone alongside insulin in type 2 diabetes mellitus.
EUCTR2006-001982-41-GBBradford Teaching Hospitals NHS Foundation Trust40
Not yet recruiting
Not Applicable
CAL(Cell assisted lipo-transfer) in treating recurrent complex anal fistula
KCT0008334Hangun Hospital Bumcheon Campus20
Active, not recruiting
Phase 1
EFFICACY AND SAFETY STUDY OF THE ANTIHISTAMINE V0114CP 2.5MG IN THE TREATMENT OF SEASONAL ALLERGIC RHINITIS. RANDOMISED, DOUBLE-BLIND, THREE ARM PARALLEL GROUP STUDY INCLUDING PLACEBO AND ACTIVE CONTROL ARM (DESLORATADINE 5 MG)The medical condition to be investigated in this study is the seasonal allergic rhinitis. The intended indication for the product is the treatment of allergic rhinitis
EUCTR2008-000133-22-PLPierre Fabre Médicament900
Not yet recruiting
Not Applicable
An Investigation of the effect of using a conformable and wearable ice pack on pain and discomfort following sacroiliac joint injection.Mechanical Sacroiliac joint dysfunctionMusculoskeletal - Other muscular and skeletal disorders
ACTRN12622000554763niveristy of Notre Dame Australia80